You are here

  • Home
  • Archive
  • Volume 9, Issue 7
  • Induction of EBV latent membrane protein-2A (LMP2A)-specific T cells and construction of individualized TCR-engineered T cells for EBV-associated malignancies

Citation Tools

Article menu
XML
Immune cell therapies and immune cell engineering
Original research
Induction of EBV latent membrane protein-2A (LMP2A)-specific T cells and construction of individualized TCR-engineered T cells for EBV-associated malignancies

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Zhang C, Tan Q, Li S, et al
Induction of EBV latent membrane protein-2A (LMP2A)-specific T cells and construction of individualized TCR-engineered T cells for EBV-associated malignancies
Journal for ImmunoTherapy of Cancer 2021;9:e002516. doi: 10.1136/jitc-2021-002516